134 related articles for article (PubMed ID: 38694214)
1. The Analysis of Human Epidermal Growth Receptor-2 (HER-2) in Gastric Cancer in a Tertiary Hospital in Sub-Saharan Africa.
Duduyemi BM; Asante E; Asiamah E; Afihene MY
Niger Med J; 2021; 62(4):178-182. PubMed ID: 38694214
[TBL] [Abstract][Full Text] [Related]
2. Her-2 Over-Expression in Gastric Carcinoma:A 5-Year Retrospective Study in A Lagos Cohort Population.
Onyekwelu VI; Badmos KB; Awolola NA; Abdulkareem FB
West Afr J Med; 2015; 34(3):150-156. PubMed ID: 28276038
[TBL] [Abstract][Full Text] [Related]
3. Sustainable Development of Pathology in Sub-Saharan Africa: An Example From Ghana.
Stalsberg H; Adjei EK; Owusu-Afriyie O; Isaksen V
Arch Pathol Lab Med; 2017 Nov; 141(11):1533-1539. PubMed ID: 28557613
[TBL] [Abstract][Full Text] [Related]
4. Human epidermal growth factor receptor 2 expression in gastric carcinoma and its association with histopathological parameters in Indian population.
Gupta P; Rao S; Bhalla S
Indian J Cancer; 2016; 53(4):505-511. PubMed ID: 28485339
[TBL] [Abstract][Full Text] [Related]
5. HER 2 expression status in gastric carcinomas in Ibadan, Nigeria: a preliminary study using immunohistochemistry.
Ogun GO; Afuwape OO; Ayandipo OO; Oluwasola OA
Niger Postgrad Med J; 2014 Sep; 21(3):231-4. PubMed ID: 25331239
[TBL] [Abstract][Full Text] [Related]
6. HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana.
Simpong DL; Asmah RH; Krampah C; Akakpo PK; Adu P; Asante DB; Naporo S; Adjei AA; Gyasi RK
ScientificWorldJournal; 2018; 2018():1564150. PubMed ID: 29725274
[TBL] [Abstract][Full Text] [Related]
7. Detection and Significance of Human Epidermal Growth Factor Receptor 2 Expression in Gastric Adenocarcinoma.
Halder S; Mallick D; Mondal P; Roy DS; Halder A; Chakrabarti S
Indian J Med Paediatr Oncol; 2017; 38(2):153-157. PubMed ID: 28900323
[TBL] [Abstract][Full Text] [Related]
8. Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population.
Shabbir A; Qureshi MA; Khalid AB; Mirza T; Shaikh A; Hasan SM
Saudi J Gastroenterol; 2018; 24(5):289-293. PubMed ID: 29806596
[TBL] [Abstract][Full Text] [Related]
9. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
10. HER 2 Expression in Gastric and Gastro-esophageal Junction (GEJ) Adenocarcinomas.
Rajagopal I; Niveditha SR; Sahadev R; Nagappa PK; Rajendra SG
J Clin Diagn Res; 2015 Mar; 9(3):EC06-10. PubMed ID: 25954623
[TBL] [Abstract][Full Text] [Related]
11. Human epidermal growth factor receptor 2 overexpression in gastric and gastroesophageal junction adenocarcinoma in patients seen at the University Teaching Hospital, Lusaka, Zambia.
Kasochi C; Julius P; Mweemba I; Kayamba V
Afr Health Sci; 2020 Dec; 20(4):1857-1864. PubMed ID: 34394249
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Venous Thromboembolism in Kumasi: A Postmortem-Based Study in a Tertiary Hospital in Ghana.
Ossei PPS; Owusu IK; Owusu-Asubonteng G; Ankobea-Kokroe F; Ayibor WG; Niako N
Clin Med Insights Circ Respir Pulm Med; 2020; 14():1179548420956364. PubMed ID: 33117036
[TBL] [Abstract][Full Text] [Related]
13. Patterns and presentations of colorectal cancer at Komfo-Anokye teaching hospital Kumasi, Ghana.
Agyemang-Yeboah F; Yorke J; Obirikorang C; Batu EN; Acheampong E; Frempong EA; Anto EO; Amankwaa B
Pan Afr Med J; 2017; 28():121. PubMed ID: 29515739
[TBL] [Abstract][Full Text] [Related]
14. Trastuzumab in gastric cancer.
Okines AF; Cunningham D
Eur J Cancer; 2010 Jul; 46(11):1949-59. PubMed ID: 20542421
[TBL] [Abstract][Full Text] [Related]
15. The range of abdominal surgical emergencies in children older than 1 year at the Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Abantanga FA; Nimako B; Amoah M
Ann Afr Med; 2009; 8(4):236-42. PubMed ID: 20139546
[TBL] [Abstract][Full Text] [Related]
16. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
Liu JN; Wang HB; Zhou CC; Hu SY
Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Metabolic Syndrome and Its Associated Risk Factors in Type 2 Diabetes: A Descriptive Cross-Sectional Study at the Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Agyemang-Yeboah F; Eghan BAJ; Annani-Akollor ME; Togbe E; Donkor S; Oppong Afranie B
Biomed Res Int; 2019; 2019():4562904. PubMed ID: 31187045
[No Abstract] [Full Text] [Related]
18. Clinicopathologic Features of Gastric and Gastrooesophageal Junction Adenocarcinoma.
Rima FA; Hussain M; Dewan RK; Haque MN; Sultana T; Chowdhury F; Aminullah M; Ferdous JN
Mymensingh Med J; 2020 Jan; 29(1):195-201. PubMed ID: 31915358
[TBL] [Abstract][Full Text] [Related]
19. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.
Villari D; Caruso R; Grosso M; Vitarelli E; Righi M; Barresi G
Pathology; 2002 Oct; 34(5):423-6. PubMed ID: 12408340
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of gastric cancer in Jos University Teaching Hospital Jos a 20 year review of cases.
Mandong BM; Manasseh AN; Tanko MN; Echejoh GO; Madaki AJ
Niger J Med; 2010; 19(4):451-4. PubMed ID: 21526638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
